Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

The treatment with valproate, acetylcarnitine, folic acid, and vitamin B12 may improve muscle strength in children with SMA without significant side effects.

Medical practitioners need to understand basic statistics to properly evaluate clinical trials and avoid unethical designs.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

The data suggests that dosing differences can help manage spasticity in patients with upper motor neuron dysfunction.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Patients prioritize quality of life, overall survival, and progression-free survival in treatment decisions for advanced breast cancer.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

The treatment combination is effective and generally safe for lung cancer.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Aminexil clinical 5 effectively reduces hair loss and is well-tolerated.

Cromolyn sodium's effectiveness for treating asthma in children under 2 is unclear, possibly more beneficial for older children, and further research is needed.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Oral baricitinib is effective and safe for treating alopecia areata.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Most people who volunteered for a health study had medical issues, showing the need for careful screening before trials.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Patients with fewer past treatments for alopecia areata respond better to baricitinib.